Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2016-01-08 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20160108 - Transparency notification of UCB SA.pdf
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is an 'updated transparency notification' filed pursuant to Belgian law regarding the 'disclosure of large shareholdings' (Article 14 of the law of 2 May 2007). It details changes in voting rights and equivalent financial instruments held by controlling persons/undertakings (UCB SA and UCB Fipar SA) as of December 31, 2015. This content directly corresponds to regulatory filings concerning significant ownership changes, which maps precisely to the 'Major Shareholding Notification' category (MRQ). The document is a detailed filing, not just an announcement of a filing (RPA/RNS).
2016-01-08 English
20160108 - Notification de transparence UCB SA.pdf
Director's Dealing Classification · 98% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) dated January 8, 2016, announcing an update to a previous transparency notification regarding significant shareholdings and assimilated financial instruments, as required by Belgian law (Article 14 of the law of May 2, 2007). It details changes in voting rights and holdings of options/assimilated instruments for UCB SA and UCB Fipar SA, referencing a situation as of December 31, 2015. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a formal regulatory filing, MRQ is more specific than the general RNS category.
2016-01-08 French
20160108 - Transparantieverklaring UCB NV.pdf
Director's Dealing Classification · 95% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and is dated January 8, 2016, issued as "gereglementeerde informatie" (regulated information). It explicitly states that UCB NV has provided the FSMA (Belgian financial regulator) with an updated transparency declaration based on Article 14 of the law on the disclosure of major shareholdings. The content details changes in voting rights and holdings of 'gelijkgestelde financiële instrumenten' (securities equivalent to voting rights) as of December 31, 2015. This type of filing, concerning major shareholdings and insider/controlling person disclosures, aligns most closely with notifications related to significant ownership changes. Among the provided codes, 'Major Shareholding Notification' (MRQ) is the most appropriate fit for disclosures mandated by major shareholding disclosure laws, even though the specific document type is a 'Transparency Declaration' under Belgian law.
2016-01-08 Dutch
151218 - Acquisition of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled 'Acquisition of own shares' and details a specific transaction where UCB SA/NV is acquiring 1,200,000 of its own shares via OTC transactions following the exercise of an early termination right under existing share swaps. It explicitly states the number of shares owned post-transaction (4,039,413 shares, representing 2.08% of total shares). This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2015-12-18 English
151218 - Acquisition d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details a transaction where UCB SA acquired 1,200,000 of its own shares via 'share swaps' and OTC counterparties. This action directly relates to the company buying back or repurchasing its own stock. This aligns perfectly with the definition for Transaction in Own Shares (Code: POS). The document is a direct announcement of this specific corporate action, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2015-12-18 French
151218 - Inkoop van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Inkoop van eigen aandelen" (Purchase of own shares) and details a specific transaction where UCB NV will acquire 1,200,000 of its own shares via 'over the counter' (OTC) transactions. It specifies the date, price, and the resulting number of shares held by the company (4,039,413 shares, representing 2.08%). This action directly corresponds to the definition of a company repurchasing or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a formal announcement of this specific corporate action, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive details of the transaction itself.
2015-12-18 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.